1. Home
  2. Labeler Index
  3. Alcon Laboratories, Inc.
  4. NDC Product Code: 0065-0006 Moxeza

NDC 0065-0006 Moxeza

View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. What is NDC 0065-0006?
  4. Moxeza Uses
  5. Active Ingredients UNII Codes
  6. Inactive Ingredients UNII Codes
  7. NDC to RxNorm Crosswalk
  8. Patient Education

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
0065-0006
Proprietary Name:
Moxeza
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Name: [5]
Alcon Laboratories, Inc.
Labeler Code:
0065
Product Label ID:
05248b68-16a9-488d-a39f-5137d2410471
Start Marketing Date: [9]
01-18-2011
Listing Expiration Date: [11]
12-31-2022
Exclude Flag: [12]
I
Code Structure:
Code Navigator:

Product Packages

NDC Code 0065-0006-03

Package Description: 3 mL in 1 BOTTLE

Price per Unit: $54.17778 per ML

Product Details

What is NDC 0065-0006?

The NDC code 0065-0006 is assigned by the FDA to the product Moxeza which is product labeled by Alcon Laboratories, Inc.. The product's dosage form is . The product is distributed in a single package with assigned NDC code 0065-0006-03 3 ml in 1 bottle . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Moxeza?

This medication is a quinolone antibiotic used for eye infections. MOXEZA® solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:Aerococcus viridans*Corynebacterium macginleyi*Enterococcus faecalis*Micrococcus luteus*Staphylococcus arlettae*Staphylococcus aureusStaphylococcus capitisStaphylococcus epidermidisStaphylococcus haemolyticusStaphylococcus hominisStaphylococcus saprophyticus*Staphylococcus warneri*Streptococcus mitis*Streptococcus pneumoniaeStreptococcus parasanguinis*Escherichia coli*Haemophilus influenzaKlebsiella pneumoniae*Propionibacterium acnesChlamydia trachomatis**Efficacy for this organism was studied in fewer than 10 infections.

Which are Moxeza UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Moxeza Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Moxeza?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:

* Please review the disclaimer below.

Patient Education

Moxifloxacin Ophthalmic


Moxifloxacin ophthalmic solution is used to treat bacterial conjunctivitis (pink eye; infection of the membrane that covers the outside of the eyeballs and the inside of the eyelids). Moxifloxacin is in a class of antibiotics called fluoroquinolones. It works by killing the bacteria that cause infection.
[Learn More]


* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".